Trial Failure Still Yields Insights for Uterine Leiomyosarcoma
Observation should be the standard of care in the adjuvant setting for high‑grade uterine leiomyosarcoma because adjuvant chemotherapy with gemcitabine plus docetaxel followed by doxorubicin fails to improve overall survival and may even reduce it.
Evidence level: Korai humán adat. Kis vagy feltáró emberi adat.
Related signals
- Telisotuzumab Vedotin + Osimertinib for Non‑Small Cell Lung Cancer
- Ramucirumab plus erlotinib in patients with untreated, EGFR‑mutated, advanced non‑small‑cell lung cancer (RELAY): a randomised, double‑blind, placebo‑controlled, phase 3 trial
- Recent advancements in lung cancer research: a narrative review
- Advances in Non-Small Cell Lung Cancer: Current Insights and Future Directions
- Structured proxy features for multimodal NSCLC survival prediction from pretreatment CT